The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global In-Vitro Cancer Diagnostics Market Research Report 2025
Synopsis
In-vitro cancer diagnostics are medical tests and assays used to detect and diagnose cancer using patient samples, such as blood, tissue, or urine.
The global In-Vitro Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for in-vitro cancer diagnostics is driven by the growing burden of cancer and the need for early and accurate cancer detection. The market's growth is also influenced by the development of novel biomarkers and advanced diagnostic technologies, leading to improved sensitivity and specificity of cancer tests.
This report aims to provide a comprehensive presentation of the global market for In-Vitro Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Cancer Diagnostics.
Report Scope
The In-Vitro Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Vitro Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Vitro Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MDx Health Quest Diagnostics
R-Biopharm AG
Signature Diagnostics
Siemens Healthcare
Randox Laboratories
Epigenomics AG
Beckman Coulter
Abbott Laboratories
Burning Rock
Novogene
Geneseeq
Amoy Diagnostics Co.,Ltd.
Daan Gene
Fosun Pharma
Segment by Type
Instruments
Reagents and Kits
Segment by Application
Laboratories
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Vitro Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In-vitro cancer diagnostics are medical tests and assays used to detect and diagnose cancer using patient samples, such as blood, tissue, or urine.
The global In-Vitro Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for in-vitro cancer diagnostics is driven by the growing burden of cancer and the need for early and accurate cancer detection. The market's growth is also influenced by the development of novel biomarkers and advanced diagnostic technologies, leading to improved sensitivity and specificity of cancer tests.
This report aims to provide a comprehensive presentation of the global market for In-Vitro Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Cancer Diagnostics.
Report Scope
The In-Vitro Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In-Vitro Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Vitro Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MDx Health Quest Diagnostics
R-Biopharm AG
Signature Diagnostics
Siemens Healthcare
Randox Laboratories
Epigenomics AG
Beckman Coulter
Abbott Laboratories
Burning Rock
Novogene
Geneseeq
Amoy Diagnostics Co.,Ltd.
Daan Gene
Fosun Pharma
Segment by Type
Instruments
Reagents and Kits
Segment by Application
Laboratories
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Vitro Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Instruments
1.2.3 Reagents and Kits
1.3 Market by Application
1.3.1 Global In-Vitro Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Cancer Diagnostics Market Perspective (2019-2030)
2.2 In-Vitro Cancer Diagnostics Growth Trends by Region
2.2.1 Global In-Vitro Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In-Vitro Cancer Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 In-Vitro Cancer Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 In-Vitro Cancer Diagnostics Market Dynamics
2.3.1 In-Vitro Cancer Diagnostics Industry Trends
2.3.2 In-Vitro Cancer Diagnostics Market Drivers
2.3.3 In-Vitro Cancer Diagnostics Market Challenges
2.3.4 In-Vitro Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue
3.1.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue (2019-2024)
3.1.2 Global In-Vitro Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Cancer Diagnostics Revenue
3.4 Global In-Vitro Cancer Diagnostics Market Concentration Ratio
3.4.1 Global In-Vitro Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Cancer Diagnostics Revenue in 2023
3.5 In-Vitro Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players In-Vitro Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into In-Vitro Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Cancer Diagnostics Breakdown Data by Type
4.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2025-2030)
5 In-Vitro Cancer Diagnostics Breakdown Data by Application
5.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In-Vitro Cancer Diagnostics Market Size (2019-2030)
6.2 North America In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
6.4 North America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Cancer Diagnostics Market Size (2019-2030)
7.2 Europe In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
7.4 Europe In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Cancer Diagnostics Market Size (2019-2030)
9.2 Latin America In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
9.4 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MDx Health Quest Diagnostics
11.1.1 MDx Health Quest Diagnostics Company Detail
11.1.2 MDx Health Quest Diagnostics Business Overview
11.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Introduction
11.1.4 MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.1.5 MDx Health Quest Diagnostics Recent Development
11.2 R-Biopharm AG
11.2.1 R-Biopharm AG Company Detail
11.2.2 R-Biopharm AG Business Overview
11.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Introduction
11.2.4 R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.2.5 R-Biopharm AG Recent Development
11.3 Signature Diagnostics
11.3.1 Signature Diagnostics Company Detail
11.3.2 Signature Diagnostics Business Overview
11.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Introduction
11.3.4 Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.3.5 Signature Diagnostics Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Detail
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Introduction
11.4.4 Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.4.5 Siemens Healthcare Recent Development
11.5 Randox Laboratories
11.5.1 Randox Laboratories Company Detail
11.5.2 Randox Laboratories Business Overview
11.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Introduction
11.5.4 Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.5.5 Randox Laboratories Recent Development
11.6 Epigenomics AG
11.6.1 Epigenomics AG Company Detail
11.6.2 Epigenomics AG Business Overview
11.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Introduction
11.6.4 Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.6.5 Epigenomics AG Recent Development
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Detail
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Introduction
11.7.4 Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.7.5 Beckman Coulter Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Detail
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Introduction
11.8.4 Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.8.5 Abbott Laboratories Recent Development
11.9 Burning Rock
11.9.1 Burning Rock Company Detail
11.9.2 Burning Rock Business Overview
11.9.3 Burning Rock In-Vitro Cancer Diagnostics Introduction
11.9.4 Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.9.5 Burning Rock Recent Development
11.10 Novogene
11.10.1 Novogene Company Detail
11.10.2 Novogene Business Overview
11.10.3 Novogene In-Vitro Cancer Diagnostics Introduction
11.10.4 Novogene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.10.5 Novogene Recent Development
11.11 Geneseeq
11.11.1 Geneseeq Company Detail
11.11.2 Geneseeq Business Overview
11.11.3 Geneseeq In-Vitro Cancer Diagnostics Introduction
11.11.4 Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.11.5 Geneseeq Recent Development
11.12 Amoy Diagnostics Co.,Ltd.
11.12.1 Amoy Diagnostics Co.,Ltd. Company Detail
11.12.2 Amoy Diagnostics Co.,Ltd. Business Overview
11.12.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Introduction
11.12.4 Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.12.5 Amoy Diagnostics Co.,Ltd. Recent Development
11.13 Daan Gene
11.13.1 Daan Gene Company Detail
11.13.2 Daan Gene Business Overview
11.13.3 Daan Gene In-Vitro Cancer Diagnostics Introduction
11.13.4 Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.13.5 Daan Gene Recent Development
11.14 Fosun Pharma
11.14.1 Fosun Pharma Company Detail
11.14.2 Fosun Pharma Business Overview
11.14.3 Fosun Pharma In-Vitro Cancer Diagnostics Introduction
11.14.4 Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2019-2024)
11.14.5 Fosun Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
